Virtuos Bone Graft in Lumbar Fusion

N/AEnrolling By InvitationNCT06686017

Orthofix Inc.150 enrolled

Overview

A post-market open label study to assess the efficacy of a cellular based allograft bone graft in lumbar spinal fusion at one or two levels

Single arm prospectively enrolled observational study of subjects who undergo lumbar spinal fusion at one or two levels with an anterior or lateral surgical approach using a cellular based allograft (Virtuos) as the bone graft There is no experimental intervention for this study. Subjects will be treated per standard of care by their attending physician/surgeon. The primary endpoint in this study is fusion success at 12 months. as determined by the attending physician/surgeon using CT as the imaging modality. The fusion rates observed at 12-months will be compared to an historical group of patients that underwent a one or two level lumbar fusion procedure with an anterior or lateral approach using a cellular based allograft (Trinity Elite).

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Degenerative Disc Disease

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Subject must be 18 years of age (≥ 18 years) or older at the time of consent. * Subject must undergo lumbar interbody fusion study at 1-2 contiguous levels. * Virtuos must be the primary bone graft (≥ 50% of the total graft volume) and may be augmented with autograft or cortical or cancellous bone chips. * Subject must be willing and able to sign an informed consent document. * Subject must be willing and able to return for all follow-up visits, agree to participate in postoperative clinical and radiographic evaluations, and comply with the required study protocol.- Exclusion Criteria: * Subject is under 18 years of age (\<18) at the time of consent. * Subject has had prior lumbar spine fusion surgery at any level. * Subject has greater than grade 1 spondylolisthesis of the lumbar spine. Subject is currently undergoing treatment for malignancy or has undergone treatment for malignancy in the past 5 years (benign skin cancer is permitted) * Subject has an active local or systemic infection or is undergoing adjunctive treatment for local or systemic infection

Locations (9)

South Bend Orthopaedics

South Bend, Indiana, United States

Michigan Orthopedic Surgeons

Southfield, Michigan, United States

Northern Rockies Orthopaedics

Missoula, Montana, United States

Pinehurst Surgical Clinic

Outcomes

Primary Outcomes

Fusion

Fusion of the spinal motion segments

Time frame: 12-months

Secondary Outcomes

Disability (ODI)

The ODI will be used to assess disability if the patient reported outcomes are routinely collected at participating centers.

Time frame: 12 months

Pain (NPRS)

A pain rating scale (VAS or NRS) will be used to assess pain levels at baseline and follow-up visits, if pain assessment is routinely collected as standard of care at participating sites. 0 will indicate no pain and 10 will indicate the highest amount of pain possible.

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.